Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Interrupting the transmission of airborne (<≈5 µm) respiratory pathogens indoors is not a new challenge, but it has attracted unprecedented interest due to the COVID-19 pandemic during 2020–2021. However, bacterial respiratory pathogens with known or potential airborne transmission account for an appreciable proportion of the communicable disease burden globally. We aimed to systematically review quantitative, laboratory-based studies of air disinfection techniques for airborne respiratory bacteria. Three databases (PubMed, Web of Science, Scopus) were searched, following PRISMA guidelines. A total of 9596 articles were identified, of which 517 were assessed in detail and of which 26 met the inclusion and quality assessment criteria. Seven air disinfection techniques, including UV-C light, filtration, and face masks, among others, were applied to 13 different bacterial pathogens. More than 80% of studies suggested that air disinfection techniques were more effective at inactivating or killing bacteria than the comparator or baseline condition. However, it was not possible to compare these techniques because of methodological heterogeneity and the relatively small number of the studies. Laboratory studies are useful for demonstrating proof-of-concept and performance under controlled conditions. However, the generalisability of their findings to person-to-person transmission in real-world settings is unclear for most of the pathogens and techniques we assessed.

Details

Title
A Systematic Literature Review of Indoor Air Disinfection Techniques for Airborne Bacterial Respiratory Pathogens
Author
Thi Tham Nguyen 1   VIAFID ORCID Logo  ; Johnson, Graham R 2 ; Bell, Scott C 3 ; Knibbs, Luke D 4 

 School of Public Health, The University of Queensland, Herston, QLD 4006, Australia; [email protected] 
 School of Earth and Atmospheric Sciences, Queensland University of Technology, Brisbane, QLD 4000, Australia; [email protected] 
 Children’s Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4101, Australia; [email protected]; Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Chermside, QLD 4032, Australia; Translational Research Institute, Brisbane, QLD 4102, Australia 
 School of Public Health, The University of Queensland, Herston, QLD 4006, Australia; [email protected]; Faculty of Medicine and Health, School of Public Health, The University of Sydney, Sydney, NSW 2006, Australia 
First page
1197
Publication year
2022
Publication date
2022
Publisher
MDPI AG
ISSN
1661-7827
e-ISSN
1660-4601
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2627535154
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.